Literature DB >> 34454062

HSymM-guided engineering of the immunodominant p53 transactivation domain putative peptide antigen for improved binding to its anti-p53 monoclonal antibody.

Zachary R Fritz1, Rene S Schloss1, Martin L Yarmush1, Lawrence J Williams2.   

Abstract

A novel engineering strategy to improve autoantibody detection with peptide fragments derived from the parent antigen is presented. The model system studied was the binding of the putative p53 TAD peptide antigen (residues 46-55) to its cognate anti-p53 antibody, ab28. Each engineered peptide contained the full decapeptide epitope and differed only in the flanking regions. Since minimal structural information was available to guide the design, a simple epitope:paratope binding model was applied. The Hidden Symmetry Model, which we recently reported, was used to guide peptide design and estimate per-residue contributions to interaction free energy as a function of added C- and N-terminal flanking peptides. Twenty-four peptide constructs were designed, synthesized, and assessed for binding affinity to ab28 by surface plasmon resonance, and a subset of these peptides were evaluated in a simulated immunoassay for limit of detection. Many peptides exhibited over 200-fold enhancements in binding affinity and improved limits of detection. The epitope was reevaluated and is proposed to be the undecapeptide corresponding to residues 45-55. HSymM calculated binding free energy and experimental data were found to be in good agreement (R2 > 0.75).
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibody; Autoantibodies; Coarse grained models; Epitope; Hidden symmetry model; Immunoassays; Paratope; Peptide engineering; Peptides; p53

Mesh:

Substances:

Year:  2021        PMID: 34454062      PMCID: PMC8526406          DOI: 10.1016/j.bmcl.2021.128341

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  39 in total

1.  Distinct peptide binding specificities of Src homology 3 (SH3) protein domains can be determined by modulation of local energetics across the binding interface.

Authors:  Maryna Gorelik; Alan R Davidson
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

2.  Diagnostic Value of Autoantibodies in Lung Cancer: a Systematic Review and Meta-Analysis.

Authors:  Jiangyue Qin; Ni Zeng; Ting Yang; Chun Wan; Lei Chen; Yongchun Shen; Fuqiang Wen
Journal:  Cell Physiol Biochem       Date:  2018-12-11

Review 3.  Peptide-based and polypeptide-based hydrogels for drug delivery and tissue engineering.

Authors:  Aysegul Altunbas; Darrin J Pochan
Journal:  Top Curr Chem       Date:  2012

Review 4.  Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering.

Authors:  Sharareh Eskandari; Thalia Guerin; Istvan Toth; Rachel J Stephenson
Journal:  Adv Drug Deliv Rev       Date:  2016-06-26       Impact factor: 15.470

Review 5.  p53 Antibodies in the sera of patients with various types of cancer: a review.

Authors:  T Soussi
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

6.  A comparative assessment and analysis of 20 representative sequence alignment methods for protein structure prediction.

Authors:  Renxiang Yan; Dong Xu; Jianyi Yang; Sara Walker; Yang Zhang
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

7.  Advancement and applications of peptide phage display technology in biomedical science.

Authors:  Chien-Hsun Wu; I-Ju Liu; Ruei-Min Lu; Han-Chung Wu
Journal:  J Biomed Sci       Date:  2016-01-19       Impact factor: 8.410

Review 8.  Peptide-Based Vaccines: Current Progress and Future Challenges.

Authors:  Ryan J Malonis; Jonathan R Lai; Olivia Vergnolle
Journal:  Chem Rev       Date:  2019-12-05       Impact factor: 60.622

9.  Peptide ligand screening of alpha-synuclein aggregation modulators by in silico panning.

Authors:  Koichi Abe; Natsuki Kobayashi; Koji Sode; Kazunori Ikebukuro
Journal:  BMC Bioinformatics       Date:  2007-11-16       Impact factor: 3.169

Review 10.  Molecular dynamics simulations: advances and applications.

Authors:  Adam Hospital; Josep Ramon Goñi; Modesto Orozco; Josep L Gelpí
Journal:  Adv Appl Bioinform Chem       Date:  2015-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.